Xlife Sciences AG (XLS)

BRIEF

published on 06/26/2024 at 07:05, 4 months 27 days ago

Xlife Sciences AG Reports Success in Liver Diagnostics

Xlife Sciences AG Medical Innovation Liver Diagnostics PET Tracer DAZAmed
PRESS RELEASE

published on 06/26/2024 at 07:00, 4 months 27 days ago

Xlife Sciences AG Reports Success in Liver Diagnostics – x-nuclear diagnostics GmbH Achieves Market Readiness
Xlife Sciences AG reports success in liver diagnostics with the market readiness of PET tracer DAZAmed by x-nuclear diagnostics GmbH, a breakthrough in medical imaging

Xlife Sciences AG Liver Diagnostics PET Tracer DAZAmed X-nuclear Diagnostics GmbH
BRIEF

published on 05/27/2024 at 07:05, 5 months 27 days ago

Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH

Merger Clinical Research Europe Healthcare Xlife Sciences
PRESS RELEASE

published on 05/27/2024 at 07:00, 5 months 27 days ago

Xlife Sciences AG Announces Strategic Merger Between palleos healthcare GmbH and OCT Clinical GmbH
Xlife Sciences AG announces strategic merger between palleos healthcare GmbH and OCT Clinical GmbH, creating a leading company in clinical research with comprehensive global services

Merger Clinical Research Xlife Sciences AG Palleos Healthcare GmbH OCT Clinical GmbH
BRIEF

published on 04/30/2024 at 07:05, 6 months 23 days ago

Xlife Sciences AG Reports Portfolio Growth and Strategic Advances

Life Sciences Industry Portfolio Growth Xlife Sciences AG 2023 Valuation Report CHF Valuation
PRESS RELEASE

published on 04/30/2024 at 07:00, 6 months 23 days ago

Xlife Sciences AG Reports Strong Portfolio Growth and Strategic Advances in the 2023 Valuation Report
Xlife Sciences AG reports strong portfolio growth and strategic advances in the 2023 Valuation Report by independent consulting firm CYLAD Experts. Portfolio valued at CHF 611.7-747.8 million

Portfolio Growth Xlife Sciences AG 2023 Valuation Report Strategic Advances CYLAD Experts
BRIEF

published on 04/23/2024 at 07:05, 7 months ago

Xlife Sciences AG Announces 2023 Annual Results and Future Outlook

Xlife Sciences AG Annual Report 2023 Regulatory Approvals Biotechnology Innovation Strategic Exits
PRESS RELEASE

published on 04/23/2024 at 07:00, 7 months ago

Xlife Sciences AG Publishes 2023 Annual Report
Xlife Sciences AG publishes 2023 Annual Report, highlighting financial and operational achievements, innovative projects, and global expansion in 2024

Financial Results Strategic Partnerships Annual Report Operational Progress Xlife Sciences AG
BRIEF

published on 04/03/2024 at 17:05, 7 months 19 days ago

Xlife Sciences AG Announces Collaboration with T-Systems Switzerland for AI-Powered Radiology Software

Healthcare Technology Xlife Sciences FUSE-AI T-Systems Switzerland Prostate.Carcinoma.ai
PRESS RELEASE

published on 04/03/2024 at 17:00, 7 months 19 days ago

Xlife Sciences AG Announces Collaboration Agreement Between its Portfolio Company FUSE-AI GmbH and T-Systems Switzerland
Xlife Sciences AG announces collaboration agreement between its portfolio company FUSE-AI GmbH and T-Systems Switzerland to distribute AI-powered software for radiology clinics. The partnership aims to increase efficiency and reduce misdiagnoses

Xlife Sciences AG T-Systems Switzerland FUSE-AI GmbH AI-powered Software Radiology Clinics

Published on 11/22/2024 at 23:55, 9 hours 22 minutes ago

Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 47 minutes ago

Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 12 minutes ago

Kidoz Inc. Announces Results of 2024 AGM
Published on 11/22/2024 at 23:05, 10 hours 12 minutes ago

Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 47 minutes ago

Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.

View all ACCESSWIRE

Published on 11/22/2024 at 18:14, 15 hours 2 minutes ago

Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 18:00, 15 hours 17 minutes ago

Holding(s) in Company
Published on 11/22/2024 at 17:53, 15 hours 24 minutes ago

Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 21 minutes ago

EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 17 minutes ago

Proposed cancellation of admission to trading

View all EQS

Published on 11/22/2024 at 14:35, 18 hours 42 minutes ago

Thales Press release
Published on 11/21/2024 at 06:58, 2 days 2 hours ago

Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago

Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago

Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024

View all LES ECHOS COMFI WIRE

News